Lv1
30 积分 2024-11-01 加入
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
3个月前
已完结
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial
3个月前
已完结
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
3个月前
已完结
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA
3个月前
已完结
The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma
3个月前
已完结
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
3个月前
已完结
Real-world outcomes of diffuse large B-cell lymphoma treated with frontline R-CHOP(-like) regimens in an Asian multi-ethnic population
3个月前
已完结
Optimizing bridging radiotherapy prior to CAR-T cell therapy: An evidence-based approach
4个月前
已关闭
Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy
4个月前
已完结
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
4个月前
已完结
皖公网安备34019202002308
